// App-Quantinova.ai

TCT-7 : Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting Stents

Researchers

Presenter

  • Joshua P. Loh

Principal Investigators

  • Salem Badr

  • Israel Barbash

  • Augusto Pichard

  • Fang Chen

  • Kenneth Kent

  • Hironori Kitabata

  • Marco A. Magalhaes

  • Sa'ar Minha

  • Al Fazir Omar

  • Hideaki Ota

  • lakshmana Pendyala

Medical Centers

  • Medstar Washington Hospital Center, Washington, DC, United States

  • Medstar Washington Hosp Ctr, Washington, DC

  • MedStar Health Research Institute, Washington, DC

  • Medstar Washington Hosp Ctr, Washington, DC

  • Medstar Washington Hosp Ctr, Washington, DC

  • Medstar Heart Institute, Washington, District Of Columbia

  • MedStar Washington Hospital Center, District of Columbia

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Everolimus

  • TAXUS

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved